wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38709303-14E03A60-1433-483C-9992-DC92D013097C
Q38709303-14E03A60-1433-483C-9992-DC92D013097C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38709303-14E03A60-1433-483C-9992-DC92D013097C
Rational design, synthesis, and biological evaluation of Pan-Raf inhibitors to overcome resistance.
P2860
Q38709303-14E03A60-1433-483C-9992-DC92D013097C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38709303-14E03A60-1433-483C-9992-DC92D013097C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27a708a4cab6512cc1b911285487a0f90475d176
P2860
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)